Literature DB >> 10693099

Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial.

D J Hoffman1, J S Gerdes, S Abbasi.   

Abstract

OBJECTIVE: To study the effect of spironolactone on dietary electrolyte supplementation, pulmonary function, and electrolyte balance in premature infants with chronic lung disease. STUDY
DESIGN: A double-blind, randomized, and placebo-controlled trial was designed to study two groups of low birth weight infants with chronic lung disease at Pennsylvania Hospital. The placebo group received chlorothiazide and a placebo, and the spironolactone group received chlorothiazide and spironolactone during the 2-week study period. A two-tailed t-test was used to determine equivalence between the two groups.
RESULTS: Pulmonary compliance, resistance and tidal volume, serum sodium and potassium, and FIO2, were not statistically different between the two groups. The need for sodium and/or potassium chloride did not differ between the two groups, nor did the quantity of each salt.
CONCLUSION: The addition of spironolactone did not reduce the requirement for supplemental electrolytes, nor did it improve pulmonary mechanics or electrolyte balance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693099     DOI: 10.1038/sj.jp.7200307

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  6 in total

Review 1.  Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion; Iris Ambrosio-Perez
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

2.  Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.

Authors:  Jonathan L Slaughter; Michael R Stenger; Patricia B Reagan
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

3.  Prevention of bronchopulmonary dysplasia.

Authors:  Matthew M Laughon; P Brian Smith; Carl Bose
Journal:  Semin Fetal Neonatal Med       Date:  2009-09-06       Impact factor: 3.926

4.  Pulmonary Function and Systolic Blood Pressure in Very Low Birth Weight Infants at 34 - 36 Weeks of Corrected Age.

Authors:  Ladawna L Gievers; Randall D Jenkins; Amy Laird; Marissa C Macedo; Diane Schilling; Cindy T McEvoy
Journal:  Res Rep Neonatol       Date:  2019-09-13

5.  Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia.

Authors:  Kristen Tropea; Helen Christou
Journal:  Int J Pediatr       Date:  2012-01-03

Review 6.  Drug therapy for the prevention and treatment of bronchopulmonary dysplasia.

Authors:  Anjali Iyengar; Jonathan M Davis
Journal:  Front Pharmacol       Date:  2015-02-16       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.